Trademark Snap Shot Amendment to Delete or Correct Basis (Table presents the data on Amendment to Delete or Correct Basis) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 97348836 | FILING DATE | 04/06/2022 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | TATE-NAGHI, JACQUELINE |
L.O. ASSIGNED | T70-NOT FOUND |
PUB INFORMATION |
|||
RUN DATE | 03/23/2023 | ||
PUB DATE | N/A | ||
STATUS | 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED | ||
STATUS DATE | 03/22/2023 | ||
LITERAL MARK ELEMENT | IRELYMI | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | NO | 1 (b) | NO |
44D | YES | 44D | NO | 44D | NO |
44E | NO | 44E | YES | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | IRELYMI |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | AstraZeneca AB |
ADDRESS | Astraallén Södertälje, SE-15185 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Sweden |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Pharmaceutical preparations and substances for the treatment of amyloidosis |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
PRIORITY CLAIMED | SEC. 44(D) ON Office for Harmonization in the Internal Market (Trade Marks and Designs) (OHIM) |
APPLICATION NO. | 018681430 |
APPLICATION FILING DATE | 04/04/2022 |
FOREIGN REG NO. | 018681430 |
FOREIGN REG DATE | 07/15/2022 |
FOREIGN RNWL NUM | N/A |
DATE OF FOREIGN RNWL | N/A |
FOREIGN EXPIRATION | 04/04/2032 |
FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
03/22/2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 010 |
03/22/2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 009 |
03/22/2023 | ALIE | A | ASSIGNED TO LIE | 008 |
01/06/2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
12/14/2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
12/14/2022 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
12/14/2022 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
12/12/2022 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
04/11/2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 002 |
04/09/2022 | NWAP | I | NEW APPLICATION ENTERED | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Cara M. Kearney |
CORRESPONDENCE ADDRESS | Cara M. Kearney ASTRAZENECA PHARMACEUTICALS LP 1800 CONCORD PIKE, A2C WILMINGTON, DE 19850-5437 |
DOMESTIC REPRESENTATIVE | Cara M. Kearney |